Transgene Biotek Ltd.

View in App
10.30 +0.49 ▲5.0%

08 December 2023, 04:01:00 PM
Volume: 623,840

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.transgenebiotek.com
Market Cap 78.04 Cr.
Enterprise Value(EV) 91.60 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.41 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 63.05 Trailing Twelve Months Ending 2023-09
Book Value / Share 1.46 Trailing Twelve Months Ending 2023-09
Price to Book Value 7.03 Calculated using Price: 10.30
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 7.58 Cr. 75,770,000 Shares
FaceValue 10
About Transgene Biotek Ltd.
Transgene Biotek Ltd (TBL) was set up in 1991, and was probably the first true Biotechnology Company in India. It is listed on the Indian Stock Exchanges and is involved in the development of several cutting edge technologies.

Transgene Biotek Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Transgene Biotek Ltd. Performance

View details >>
1 Day
+4.99%
1 Week
+32.05%
1 Month
+110.63%
3 Month
+128.89%
6 Month
+170.34%
1 Year
+265.25%
2 Year
+157.50%
5 Year
+215.95%
10 Year
+193.45%

Transgene Biotek Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -9.63 -11.78 -17.03 -11.57 -18.31 -28.73 -38.00 -52.51 -41.80
Return on Capital Employed (%) -8.84 -10.85 -14.68 -6.74 -14.83 -22.10 -26.55 -32.32 -19.99
Return on Assets (%) -5.45 -6.56 -7.77 -3.35 -4.84 -6.39 -6.45 -6.84 -4.15

Transgene Biotek Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 191 174 59 52 44 33 22 17 11 11
Non Curr. Liab. 127 127 127 120 120 120 120 121 121 121
Curr. Liab. 25 11 12 14 13 14 14 9 10 11
Minority Int.
Equity & Liab. 344 313 198 187 177 167 157 147 142 142
Non Curr. Assets 326 310 197 186 176 166 156 146 141 141
Curr. Assets 18 3 1 1 1 1 1 1 1 1
Misc. Exp. not W/O
Total Assets 344 313 198 187 177 167 157 147 142 142

Transgene Biotek Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 0 0 0 0 0 0 0 0 0
Other Income 0 0 1 7 2 0 0 0 0 0
Total Income 0 0 1 7 2 0 0 0 0 0
Total Expenditure -2 -1 -3 -2 -1 -1 -1 -1 -1 -1
PBIDT -2 -1 -2 5 1 -1 0 0 0 0
Interest 0 0 0 -1 0 0 0 0 -1 0
Depreciation -17 -21 -18 -10 -10 -10 -10 -10 -5 -3
Taxation -1
Exceptional Items
PAT -19 -22 -20 -6 -9 -11 -10 -10 -6 -3
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -19 -22 -20 -6 -9 -11 -10 -10 -6 -3
Adjusted EPS -3 -3 -3 -1 -1 -1 -1 -1 -1 0

Transgene Biotek Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -2 4 6 0 -1 -2 0 0 0
Cash Fr. Inv. 1 -5 -6 3 2 0 0 0
Cash Fr. Finan. 1 1 -2 0
Net Change 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0

Transgene Biotek Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 23.64 23.64 23.64 23.64 23.64 23.64 23.64 23.64 23.64
Public 76.36 76.36 76.36 76.36 76.36 76.36 76.36 76.36 76.36
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Transgene Biotek Ltd. Announcements

View details >>
Sat, 02 Dec 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement- Notice of 33rd Annual General Meeting Remote E-voting information Record date and Book Closure etc.
Fri, 01 Dec 2023
Reg. 34 (1) Annual Report.
33rd Annual Report 2022-2023.
Fri, 01 Dec 2023
Intimation Of Book Closure And Cut-Off Date For The 33Rd Annual General Meeting Of M/S.Transgene Biotek Limited.
Intimation of Book Closure.

Transgene Biotek Ltd. Technical Scans

View details >>
Fri, 08 Dec 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing 52 Week High Close Crossing 52 Week High
Opening at High Opening at High

Transgene Biotek Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,437.84 1,235.50 -0.3%
Cipla Ltd. 98,403.90 1,218.85 -0.3%
Divi's Laboratories Ltd. 97,728.28 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. 96,135.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. 79,685.46 5,542.00 +1.5%
Mankind Pharma Ltd. 78,250.95 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. 69,584.38 2,056.00 -2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 28.50 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 73.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.88 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.25 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 61.04 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.16 2,056.00 -2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 3.96 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 7.71 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.77 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.26 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.37 2,056.00 -2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,056.00 -2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,056.00 -2.2%

Transgene Biotek Ltd. FAQ's

What is Transgene Biotek share price?
Can I buy Transgene Biotek shares now?
What is the Market Cap of Transgene Biotek?
What are the key metrics to analyse Transgene Biotek?
What is the 52 Week High and Low of Transgene Biotek?
What is the trend of Transgene Biotek share price?